INTRODUCTION
Toll-like receptors (TLRs) activate cells of the innate immune system in response to conserved structures of the pathogens. 1 Originally identified as the predominant LPS receptor, 2,3 TLR4 has subsequently been shown to also recognize protein F from respiratory syncytial virus, 4 taxol, 5 fibronectin, 6 and endogenous HSP 60. 7 A small secreted protein, MD-2, is necessary for initiating TLR4-mediated LPS responses 8 via an intracellular pathway that involves MyD88, IL-1R-associated kinase (IRAK), Tollip, [9] [10] [11] [12] [13] [14] TRAF-6, ECSIT, and TAK-1, [15] [16] [17] which ultimately results in activation of mitogen-activated protein (MAP) kinases and transcription factors. TLR4 also triggers the MyD88independent pathway via recruitment of the Toll-IL-1R adapter protein (TIRAP)/MyD88-like adapter (MAL), 18, 19 which mediates delayed NF-kB, MAP kinase activation, 20 and dendritic cell maturation. 21 LPS tolerance is a transient state of LPS refractoriness following LPS pretreatment, 22 which is reminiscent of suppressed LPS-mediated responses in survivors of septic shock. 23 Whereas decreased cell-surface expression of TLR4-MD-2 has been reported to underlie LPS tolerance, 24 others have proposed that suppressed LPS-induced IRAK kinase activity and diminished IRAK-MyD88 association mediates the LPS-tolerant state. 25 In addition, tolerance induction to bacterial flagellin does not affect the expression of TLR5, but blocks release of IRAK from TLR5. 26 Hence, induction of microbial tolerance is likely to affect intracellular intermediates downstream of TLRs. That TLR4 and TLR2 agonists induce a state of cross-tolerance 27, 28 and LPStolerant cells exhibit suppressed LPS-induced TLR4-MyD88 association and IRAK-1 activation 29 also favors this hypothesis. In this study, we examined whether LPS tolerance may be induced under conditions where expression of TLR4 and MD-2 proteins is not affected. We found that overexpression of CD14, TLR4, and MD-2 confers LPS sensitivity to otherwise LPS-unresponsive HEK 293T cells, but does not prevent induction of LPS tolerance, despite the lack of down-regulation of TLR4 or MD-2 protein expression by LPS pretreatment.
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MATERIALS AND METHODS

Cells and reagents
HEK 293T cells were cultured in DMEM medium (BioWhittaker, Walkersville, MD, USA) supplemented with 10% FBS, 2 mM L-glutamine, 100 units/ml penicillin, and 100 mg/ml streptomycin. Protein-free, phenol/water-extracted Escherichia coli LPS K235 was prepared as described. 30 Human recombinant TNF-a was from R&D Systems, Inc. (Minneapolis, MN, USA), anti-Flag M2 mAb was from Sigma (St Louis, MO, USA), anti-ACTIVE MAP kinase polyclonal Ab directed to phosphorylated forms of ERK1/2 was from Promega (Madison, WI, USA), and mouse anti-MYC Ab was from Invitrogen Inc. (Carlsbad, CA, USA). Donkey anti-rabbit and anti-mouse HRP-conjugates were purchased from Amersham Biosciences, Inc.
(Piscataway, NJ, USA). The expression vectors pCDNA3-huCD14 and pCDNA3-Myc-huTLR4 were kindly provided by Dr D.T. Golenbock (University of Massachusetts Medical School, Worcester, MA, USA), and the pEFBOS-Flag-huMD-2 plasmid was a gift from Dr K. Miyake (Saga Medical School, Saga, Japan).
Reporter assay
Cells were seeded into 12-well plates (Costar) at 2 x 10 5 cells/well, incubated overnight, and co-transfected for 3 h with the pCDNA3-huCD14, pCDNA3-Myc-huTLR4, pEFBOS-Flag-huMD-2 plasmids (0.3 mg/well each) together with the NF-kB reporter (0.5 mg/well) with SuperFect transfection reagent (Qiagen Inc., Valencia, CA, USA). Cells were recovered for 20 h, pretreated with medium or LPS for 18 h, washed and restimulated with LPS for 5 h. Cells were lysed, and luciferase activities were analyzed in cellular extracts with equal amounts of protein with the luciferase assay system (Promega), using a Monolight 2010 luminometer (Analytical Luminescence Laboratory).
Western blot analysis
Cells were plated in 100-mm Petri dishes (2.5 x 10 6 cells/dish), grown overnight, and co-transfected for 3 h with the pCDNA3-huCD14, pCDNA3-MYChuTLR4, pEFBOS-Flag-huMD-2 expression vectors (3 mg of each) and 1 mg of pCDNA3 using the SuperFect Transfection Reagent. Following pretreatment and re-stimulation, cellular extracts were prepared as described, 27 resolved on 4-12% SDS-PAGE gradient gels (Invitrogen) in Tris/glycine/SDS buffer (25 mM Tris, 250 mM glycine, 0.1% SDS), and transferred onto Immubilon P transfer membranes. After blocking for 2 h in TBS-T (20 mM Tris-HCl, 150 mM NaCl, 0.1% Tween 20), containing 5% nonfat milk, membranes were washed 3 times in TBS-T and probed for 20 h at 4°C with the respective Abs diluted in TBS-T/5% non-fat milk. Membranes were washed 3 times in TBS-T and incubated for 1 h with secondary HRP-conjugated Ab (1:10,000 dilution). After washing 5 times in TBS-T, bands were detected with enhanced chemiluminescence (ECL)-plus reagents (Amersham Pharmacia Biotech).
RT-PCR
Total RNA was isolated by using RNA Stat60 isolation reagent (Tel-Test 'B', Friendswood, TX, USA), as specified by the manufacturer and quantified spectrophotometrically. Relative quantities of mRNA for TLR4, MD-2, and b-actin were determined by a semiquantitative RT-PCR using the following sense (S) and antisense (AS) primers: TLR4, 5k -CGGATGGCAACATTTAGA-ATTAGT-3k (S), 5k -TGATTGAGACTGTAATCAAGA-ACC-3k (AS); MD-2, 5k-TCCATATTTACTGAA GCTCAGAAGCAG-3k (S), 5k -GGTTGGTGTAGG-ATGACAAACTCCAAG-3k (AS); and b-actin, 5k-GATGATATCGCCGCGCTCGT-3k(S), 5k -GTAGATGGG CACAGTGTGGGTG-3k(AS). The optimal cycle number for each gene was chosen to detect PCR-amplified products under non-saturating conditions. Each cycle consisted of 1 min at 95°C, 1 min at a gene-specific annealing temperature (54°C for TNF-a and TLR4, 56°C for b-actin, 57°C for MD-2), and 1-min primer extension at 72°C.
RESULTS AND DISCUSSION
Our first goal was to choose cells that lack endogenous components of the LPS receptor complex, are LPS-unresponsive, but acquire high LPS sensitivity following transfection of CD14, TLR4, and MD-2. This would ensure that LPS-tolerance induction is studied in cells whose LPS receptors are represented by transfected molecules, ruling out possible LPS interference with the expression of endogenous CD14, TLR4, and MD-2 proteins. Human HEK 293T cells do not express endogenous CD14, TLR4, and MD-2 ( Fig. 1A and data not shown) and are completely LPS unresponsive. 31, 32 Transient transfection of HEK 293T cells with CD14, TLR4, and MD-2 conferred upon them the ability to respond to LPS by NF-kB activation (Fig. 1B) , whereas co-transfection of CD14 together with either TLR4 alone or MD-2 alone did not ( Fig. 1B and data not shown). Of note, TNF-a caused similar induction of NF-kB-dependent transcription of luciferase (Luc) gene regardless of co-transfection ( Fig. 1B) . Thus, consistent with previously published data, 31, 32 these results show that CD14, TLR4, and MD-2 proteins are necessary and sufficient for conferring LPS responsiveness upon HEK 293 cells. Next, we sought to determine whether endotoxin tolerance could be induced in HEK 293T cells that overexpress CD14, TLR4, and MD-2, as well as the effect of LPS pretreatment and re-stimulation on the expression of TLR4 and MD-2 proteins. Figure 2 shows that in medium-pretreated cells, LPS stimulation resulted in dose-dependent activation of the NF-kB reporter and time-dependent ERK 1/2, phosphorylation. LPS-pretreated cells showed elevated basal levels of NF-kB transactivation; however, subsequent re-stimulation with LPS did not further activate the NF-kB reporter ( Fig. 2A ). Likewise, slightly increased levels of p-ERK 1/2 MAP kinases (Fig. 2B) were seen in HEK 293T/CD14/TLR4/MD-2 cells pretreated with LPS compared to those detected in medium-pretreated cells. LPS re-stimulation of cells previously exposed to LPS led to a very small, if any, increase in the phosphorylation of ERK 1/2, which was significantly lower than the LPS response in medium-pretreated cells (Fig. 2B ). Neither LPS pretreatment nor re-stimulation had any effect on the levels of transfected TLR4 and MD-2 proteins in HEK 293T cells (Fig. 2B) , indicating that LPS-tolerance induction in this system cannot be explained by downregulation of TLR4-MD-2 expression.
The results presented herein extend our previous data that show induction of LPS tolerance in Chinese hamster ovary (CHO) cells stably transfected with human TLR4 and MD-2 under conditions where the cell-surface expression of transfected TLR4 and MD-2 was not influenced by LPS. 28 Human HEK 293T cells do not express endogenous CD14, TLR4, and MD-2, as evidenced by RT-PCR, as well as by functional assays. Overexpression of CD14, TLR4, and MD-2 rendered HEK 293T cells highly LPS-sensitive. As HEK 293T cells lack endogenous TLR4/MD-2, transfected proteins were the only TLR4/MD-2 molecules present in these cells. The fact that LPS pretreatment effectively induces endotoxin tolerance in HEK 293T cells that overexpress CD14, TLR4, and MD-2 without affecting the expression of transfected proteins indicates the existence of 62 Medvedev, Vogel Fig. 1 . Co-transfection of HEK 293T cells with CD14, TLR4, and MD-2 confers LPS responsiveness. (A) Analysis of the expression of mRNA for TLR4 and MD-2 in cells transfected with pCDNA3-huCD14 only or with pCDNA3-huCD14, pCDNA3-huTLR4, and pEFBOS-Flag-huMD-2 by semiquantitative RT-PCR. Cells were plated in 6-well plates (1 x 10 6 cells/well), cultured overnight, transfected for 3 h with the expression vectors as shown, and permitted to recover overnight. Thereafter, RNA was isolated and subjected to RT-PCR analysis with primers specific for human TLR4, MD-2, and b-actin. Shown are the results in triplicate performed for each transfection. (B) NF-kB reporter assay. Cells were co-transfected for 3 h in two groups -with either pCDNA3-huCD14, pCDNA3-huTLR4, pEFBOS-Flag-huMD-2, and pELAM-Luc or with pCDNA3-huCD14, pCDNA3-huTLR4, and pELAM-Lucpermitted to recover overnight, and stimulated for 5 h with medium, 100 ng/ml LPS, or 50 ng/ml TNF-a. Cells were lyzed and Luc activity assayed as described in Materials and Methods. mechanisms of LPS tolerance distinct from down-regulation of expression of the TLR4 and MD-2 complex. This conclusion is supported by previous observations on the induction of cross-tolerance in mouse macrophages by LPS and IL-1 that act via different cell surface receptors, 27 and by LPS and highly purified TLR2-specific lipoteichoic acid that engage TLR4 and TLR2, respectively. 33 In addition, LPS induces cross-tolerance (as assessed by NF-kB activation) to mycobacterial TLR2 ligands (lipoarabinomannan and soluble tuberculosis factor) in CHO cells that overexpress human CD14 and TLR2 without downregulation of cell-surface expression of TLR2. 28 The TLR5 agonist, flagellin, induces tolerance to itself without inhibiting expression of TLR5. 26 Moreover, if one postulates that LPS tolerance occurs due to down-regulation of the LPS receptor complex, TLR4-MD-2, then all LPSinduced responses are likely to be inhibited as TLR4 and MD-2 are prerequisite for enabling cell sensitivity to LPS. 31, 32 However, LPS-mediated induction of IL-10, IL-1R antagonist, and TNFRII is not inhibited in LPS-tolerant cells, 34 and we would suggest that LPS-tolerance induction is mediated by dysregulation of the complex interplay and cross-talk among several intracellular intermediates. Several examples of such an effect can be found in the literature, e.g. suppression of LPS-induced IRAK kinase activity and disruption of LPS-mediated IRAK-MyD88 complex formation in human THP-1 cells rendered endotoxin-tolerant, 25 and a block of flagellin-induced IRAK-1 release from TLR5 in flagellin-tolerant small intestinal cells. 26 More recently, we have found that LPS-tolerant human monocytes and CHO/TLR4/MD-2 cells exhibit decreased recruitment of MyD88 to TLR4 in response to LPS re-stimulation, 29 extending the notion that protein-protein interactions among intracellular signal transducers of the TLR pathway could be severely affected in the course of endotoxin tolerization.
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This study was supported by NIH grants AI-44936 and AI-18797. Fig. 2 . LPS induces a tolerant state in HEK 293T cells that overexpress CD14, TLR4, and MD-2. Cells were co-transfected for 3 h with pCDNA3-huCD14, pCDNA3-huTLR4, and pEFBOS-Flag-huMD-2. Where NF-kB transactivation was assayed, cells were additionally co-transfected with the NF-kB reporter pELAM-Luc. After recovering for 20 h, cells were pretreated for 18 h with either medium or 0.1 ng/ml LPS, washed, and re-stimulated with the indicated concentrations of LPS for 5 h (NF-kB transactivation (A), or with 100 ng/ml LPS for the indicated time points (Western blot analysis, B). Thereafter, cells were lysed, and cellular extracts were prepared for measuring Luc activity and MAP kinase phosphorylation.
